ES2069894T3 - Una preparacion anticoagulante. - Google Patents

Una preparacion anticoagulante.

Info

Publication number
ES2069894T3
ES2069894T3 ES91912208T ES91912208T ES2069894T3 ES 2069894 T3 ES2069894 T3 ES 2069894T3 ES 91912208 T ES91912208 T ES 91912208T ES 91912208 T ES91912208 T ES 91912208T ES 2069894 T3 ES2069894 T3 ES 2069894T3
Authority
ES
Spain
Prior art keywords
epi
increase
anticoagulant preparation
anticoagulant
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91912208T
Other languages
English (en)
Inventor
Ole Juul Nordfang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2069894T3 publication Critical patent/ES2069894T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

PARA LA PROFILAXIS O EL TRATAMIENTO DE ENFERMEDADES DE LA COAGULACION O DEL CANCER SE ADMINISTRA UN INHIBIDOR DE LA LINEA EXTRINSICA (EPI) JUNTO CON HEPARINA U OTRO MUCOPOLISACARIDO AL PACIENTE. DE ESTA FORMA SE OBTIENE UNA ACTIVIDAD COAGULANTE INCREMENTADA ASI COMO UN INCREMENTO DE LA VIDA MEDIA DEL EPI INYECTADO EN EL PLASMA.
ES91912208T 1990-06-19 1991-05-30 Una preparacion anticoagulante. Expired - Lifetime ES2069894T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
ES2069894T3 true ES2069894T3 (es) 1995-05-16

Family

ID=8105367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91912208T Expired - Lifetime ES2069894T3 (es) 1990-06-19 1991-05-30 Una preparacion anticoagulante.

Country Status (11)

Country Link
EP (1) EP0535129B1 (es)
JP (1) JP3362038B2 (es)
AT (1) ATE119781T1 (es)
AU (1) AU645581B2 (es)
BG (1) BG61181B1 (es)
CA (1) CA2085101A1 (es)
DE (1) DE69108242T2 (es)
DK (2) DK148890D0 (es)
ES (1) ES2069894T3 (es)
HU (1) HU221323B1 (es)
WO (1) WO1991019514A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders
IL108798A0 (en) * 1993-03-02 1994-06-24 Novo Nordisk As Non-glycosylated tfpi analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
PL374506A1 (en) 2001-10-15 2005-10-31 Chiron Corporation Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3170001D1 (en) * 1980-09-30 1985-05-23 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
BG61181B1 (bg) 1997-02-28
EP0535129B1 (en) 1995-03-15
WO1991019514A1 (en) 1991-12-26
DE69108242D1 (de) 1995-04-20
JP3362038B2 (ja) 2003-01-07
DK148890D0 (da) 1990-06-19
ATE119781T1 (de) 1995-04-15
CA2085101A1 (en) 1991-12-20
EP0535129A1 (en) 1993-04-07
DE69108242T2 (de) 1995-07-06
DK0535129T3 (da) 1995-08-07
HUT63578A (en) 1993-09-28
JPH05507926A (ja) 1993-11-11
HU221323B1 (en) 2002-09-28
AU8060491A (en) 1992-01-07
AU645581B2 (en) 1994-01-20
HU9204036D0 (en) 1993-03-29

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
DK1267897T3 (da) Behandling af kongestiv hjerteinsuffiens med forbehandlet autologt blod
ES2069894T3 (es) Una preparacion anticoagulante.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE307634T1 (de) Photopherese-behandlung von hcv-infektionen
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
DE60115432D1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
EE200200596A (et) Mobiliseeriva toimega preparaat
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
RU92016457A (ru) Антикоагулирующий препарат
EP0340933A3 (en) Heparin-containing formulations
EA200400817A1 (ru) Идрапаринукс для лечения и вторичной профилактики случаев венозной тромбоэмболии у пациентов с тромбозом глубоких вен
DE69128465T2 (de) Heparinneutralisierung durch blutplättchenfaktor
Balas et al. Venous Thrombosis in Childhood
Forman Verrucose Dermatitis of Amputation Stump
Burrows After-Results of Treatment of Severe Lupus with Finsen Light (8 Cases)
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції
IT8207050V0 (it) Strumento medicale monouso atto per determinare la natura delle affezioni allergiche, tramite cutireazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535129

Country of ref document: ES